Inhibition of Plasmodium falciparum dihydropteroate synthetase and growth in vitro by sulfa drugs

The Michaelis-Menten inhibitory constants (Kis) and the concentrations required for 50% inhibition of the Plasmodium falciparum dihydropteroate synthetase were determined for six sulfa drugs. These drugs inhibited the in vitro growth of P. falciparum (50% lethal concentration) at concentrations of 30 to 500 nM; these concentrations were 100 to 1,000 times lower than the concentrations required for 50% inhibition and Kis (6 to 500 microM). The uptake of p-aminobenzoic acid was not inhibited by the sulfa drugs. However, infected erythrocytes took up more labeled sulfamethoxazole than did uninfected erythrocytes. Thus, the concentration of sulfa drugs by malaria parasites may explain how sulfa drugs inhibit in vitro growth of parasites through the inhibition of dihydropteroate synthetase.

[1]  W. Trager,et al.  Human malaria parasites in continuous culture. , 1976, Science.

[2]  R. Ferone The enzymic synthesis of dihydropteroate and dihydrofolate by Plasmodium berghei. , 1973, The Journal of protozoology.

[3]  T. Maren,et al.  Inhibition of Dihydropteroate Synthetase from Escherichia coli by Sulfones and Sulfonamides , 1973, Antimicrobial Agents and Chemotherapy.

[4]  W. Watkins,et al.  Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro. , 1984, The American journal of tropical medicine and hygiene.

[5]  R. D. Walter,et al.  7,8-Dihydropteroate-synthesizing enzyme from Plasmodium chabaudi. , 1980, Methods in enzymology.

[6]  W. O'Sullivan,et al.  Synergistic antimalarial activity of dapsone/dihydrofolate reductase inhibitors and the interaction of antifol, antipyrimidine and antipurine combinations against Plasmodium falciparum in vitro. , 1987, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[7]  V. Stitt Stevens-Johnson syndrome: a review of the literature. , 1988, Journal of the National Medical Association.

[8]  W. Watkins,et al.  Antagonism of sulfadoxine and pyrimethamine antimalarial activity in vitro by p-aminobenzoic acid, p-aminobenzoylglutamic acid and folic acid. , 1985, Molecular and biochemical parasitology.

[9]  K. Blanchard Antimalarial drugs. , 1947, Annual review of biochemistry.

[10]  R. D. Walter,et al.  Biosynthesis of Folic Acid Compounds in Plasmodia. Purification and Properties of the 7,8-Dihydropteroate-Synthesizing Enzyme from Plasmodium chabaudi , 2009, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.

[11]  C. Brockelman,et al.  Plasmodium falciparum in continuous culture: a new medium for the in vitro test for sulfadoxine sensitivity. , 1982, Bulletin of the World Health Organization.

[12]  M. N. Disraely,et al.  THE ENZYMATIC SYNTHESIS OF FOLATE-LIKE COMPOUNDS FROM HYDROXYMETHYLDIHYDROPTERIDINE PYROPHOSPHATE. , 1964, The Journal of biological chemistry.

[13]  A. Jung,et al.  Mechanisms of sulfadoxine resistance in Plasmodium falciparum. , 1986, Molecular and biochemical parasitology.

[14]  D. Warhurst Antimalarial drugs. An update. , 1987, Drugs.

[15]  Ernest Beutler,et al.  Red Cell Metabolism: A Manual of Biochemical Methods , 1975 .

[16]  W. Watkins,et al.  In vitro antimalarial activity of tetrahydrofolate dehydrogenase inhibitors. , 1984, The American journal of tropical medicine and hygiene.